Codexis, Inc. announced on February 13, 2024, Jennifer Aaker, Ph.D. provided notice to the board of directors of Codexis, Inc. of her intention not to stand for reelection to the Board at the expiration of her current term at the company?s 2024 Annual Meeting of Stockholders (the 2024 Annual Meeting). Dr. Aaker?s decision not to stand for reelection is not the result of any disagreement with the company on any matter relating to its operations, policies, practices or otherwise. Dr. Aaker will remain a director until the 2024 Annual Meeting.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.66 USD | +0.38% | -6.01% | -12.79% |
Apr. 11 | Codexis, Inc. Appoints Carole Cobb to Its Strategic Advisory Board | CI |
Feb. 29 | Benchmark Upgrades Codexis to Buy From Hold, Price Target is $9 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.79% | 188M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CDXS Stock
- News Codexis, Inc.
- Codexis, Inc. Announces Not to Stand for Reelection of Jennifer Aaker as Board of Director